Business Wire

Dubai Health Authority Implements Masimo Patient SafetyNet™

Del

Masimo (NASDAQ:MASI) announced today that the Dubai Health Authority (DHA), the government organization that oversees the healthcare systems of Dubai, is augmenting its current inventory of Masimo equipment and technology with the implementation of Masimo Patient SafetyNet™*, a supplemental remote monitoring and clinician notification system, at two hospitals in Dubai.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170813005035/en/

Masimo Patient SafetyNet enables information from bedside monitors, such as Masimo Root® with the Radical-7® or wearable Radius-7® Pulse CO-Oximeter®, to be accessible from a central viewing station. When changes occur in measured values, which may indicate deterioration in a patient’s condition, Patient SafetyNet automatically sends wireless alerts directly to clinicians, wherever they may be. In addition, Patient SafetyNet can automate the transfer of patient data, including admission data, vital signs, early warning scores (EWS), and other physiological parameters, directly to hospital electronic medical record (EMR) systems, helping to improve clinician workflows and reduce the possibility of transcription errors.

Dr. Andreas Taenzer and colleagues found in an 11-month study conducted at Dartmouth-Hitchcock Medical Center that using Patient SafetyNet and Masimo SET® pulse oximetry as part of a comprehensive alarm management strategy reduced rescue events by 65% and intensive care unit transfers by 48%, and as a result, reduced costs by $1,480,000.1,2 In a subsequent article, they announced that after five years, Dartmouth-Hitchcock had had zero preventable deaths or instances of brain damage due to opioids since the installation of Patient SafetyNet.2 In 2016, after ten years, they reported achieving a 50% reduction in unplanned ICU transfers and a 60% reduction in rescue events, despite increases in patient acuity and occupancy.3

The two Dubai Health Authority medical centers implementing Patient SafetyNet are Dubai Hospital (625 beds), which provides general medical and surgical care, and Latifa Hospital (367 beds), which specializes in maternal and child care. Dubai Hospital installed its first Patient SafetyNet in 2013. Latifa Hospital is in the process of installing four systems, with a further system planned for Dubai Hospital. “We are excited to deepen our partnership with Masimo,” said Humaid Al Qatami, Chairman of the Board and Director General of Dubai Health Authority. “The Dubai Health Authority’s mission is to develop an integrated and sustainable healthcare system that ensures our comprehensive services achieve the highest international standards, and we believe that Masimo’s monitoring devices, now even more connected to hospital infrastructure through the power of Patient SafetyNet, will help us meet that goal.”

“Patient SafetyNet, in conjunction with Masimo SET® pulse oximetry, enables continuous supplemental monitoring of active patients in post-surgical wards and can help save the lives of patients on opioids, among many other benefits,” said Joe Kiani, Founder and CEO of Masimo. “We applaud the Dubai Health Authority, dedicated to providing no less than the best health care in the world, for recognizing the importance of implementing such a proven and powerful centralized monitoring and patient surveillance system.”

@MasimoInnovates | #Masimo

References

  1. Taenzer AH et al. Impact of Pulse Oximetry Surveillance on Rescue Events and Intensive Care Unit Transfers: A Before-and-After Concurrence Study. Anesthesiology. 2010 Feb;112(2):282-7.
  2. Taenzer AH et al. Postoperative Monitoring – The Dartmouth Experience. Anesthesia Patient Safety Foundation Newsletter Spring-Summer 2012. Available online.
  3. McGrath SP et al. Surveillance Monitoring Management for General Care Units: Strategy, Design, and Implementation. The Joint Commission Journal on Quality and Patient Safety. 2016 Jul;42(7):293-302.

*The use of the trademark SafetyNet is under license from University HealthSystem Consortium.

About Masimo

Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care. In 1995, the company debuted Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, which has been shown in multiple studies to significantly reduce false alarms and accurately monitor for true alarms. Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates,1 improve CCHD screening in newborns,2 and, when used for continuous monitoring with Masimo Patient SafetyNet™* in post-surgical wards, reduce rapid response activations and costs.3,4,5 Masimo SET® is estimated to be used on more than 100 million patients in leading hospitals and other healthcare settings around the world,6 and is the primary pulse oximetry at 16 of the top 20 hospitals listed in the 2016-17 U.S. News and World Report Best Hospitals Honor Roll.7 In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), and more recently, Oxygen Reserve Index (ORi™), in addition to SpO2, pulse rate, and perfusion index (Pi). In 2014, Masimo introduced Root®, an intuitive patient monitoring and connectivity platform with the Masimo Open Connect™ (MOC-9™) interface, enabling other companies to augment Root with new features and measurement capabilities. Masimo is also taking an active leadership role in mHealth with products such as the Radius-7™ wearable patient monitor, iSpO2 ® pulse oximeter for smartphones, and the MightySat™ fingertip pulse oximeter. Additional information about Masimo and its products may be found at www.masimo.com. Published clinical studies on Masimo products can be found at http://www.masimo.com/cpub/clinical-evidence.htm.

ORi has not received FDA 510(k) clearance and is not available for sale in the United States.

*The use of the trademark Patient SafetyNet is under license from University HealthSystem Consortium.

References

  1. Castillo A et al. Prevention of Retinopathy of Prematurity in Preterm Infants through Changes in Clinical Practice and SpO2 Technology. Acta Paediatr. 2011 Feb;100(2):188-92.
  2. de-Wahl Granelli A et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ. 2009;Jan 8;338.
  3. Taenzer AH et al. Impact of Pulse Oximetry Surveillance on Rescue Events and Intensive Care Unit Transfers: A Before-And-After Concurrence Study. Anesthesiology. 2010; 112(2):282-287.
  4. Taenzer AH et al. Postoperative Monitoring – The Dartmouth Experience. Anesthesia Patient Safety Foundation Newsletter. Spring-Summer 2012.
  5. McGrath SP et al. Surveillance Monitoring Management for General Care Units: Strategy, Design, and Implementation. The Joint Commission Journal on Quality and Patient Safety. 2016 Jul;42(7):293-302.
  6. Estimate: Masimo data on file.
  7. http://health.usnews.com/health-care/best-hospitals/articles/best-hospitals-honor-roll-and-overview.

Forward-Looking Statements

This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the potential effectiveness of Masimo Patient SafetyNet™. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions regarding the repeatability of clinical results; risks related to our belief that Masimo's unique noninvasive measurement technologies, including Masimo Patient SafetyNet, contribute to positive clinical outcomes and patient safety; risks related to our belief that Masimo noninvasive medical breakthroughs provide cost-effective solutions and unique advantages; as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

Contact information

Masimo
Evan Lamb, 949-396-3376
elamb@masimo.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Savi Adds Supply Chain Star Johannes Giloth to Advisory Board21.2.2018 13:02Pressemelding

Savi®, an innovator in big data/machine learning analytic solutions, supply chain management software, and sensor technology, today announced that Johannes Giloth has joined its board of advisers. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221005117/en/ Johannes Giloth (Photo: Business Wire) Giloth is a long-time leader in procurement, supply chain and manufacturing. He currently serves as Chief Procurement Officer and Senior Vice President of Operations at Nokia where he is in charge of every aspect of operations accountability worldwide — from demand planning to execution, procurement to manufacturing. “Johannes understands the impact the explosion of data will have on the supply chain. And his tremendous success as an innovative supply chain leader proves he knows what companies need to transform their supply chains,” said Rich Carlson, CEO of Savi Technology. “I’m thrilled to have him join Savi’s advisory board. As

Mavenir Unveils Its Industry First Mobile-Native UCaas Solution, Entering into a New UCC Market Category21.2.2018 13:00Pressemelding

Mavenir, a leader in mobile network transformation, today announced its industry first Mobile-Native Unified Communications and Collaboration as a Service (mUCaaS) solution, uniquely designed to address the specific mobility needs of SOHO and SMBs. Using mobile native wireless technologies while still supporting current communications desktop usage is a complete paradigm shift compared to traditional UCaaS offerings. Leveraging Mavenir’s expertise in mobile networks with Voice over LTE (VoLTE) and Rich Communication Services (RCS), the solution provides new recurring-revenue opportunities for mobile network operators (MNOs) while addressing the real business need for truly mobile communications for the workforce. MNOs are under pressure in the consumer market with flat growth, an intensive price war on voice and data plans, and fierce competition from OTT applications. The Enterprise market offers a better outlook with UCaaS telephony and messaging projecting growth of 15.2% CAGR1 2016

Medical Technology Leaders to Discuss Open Data During World Patient Safety, Science & Technology Summit21.2.2018 13:00Pressemelding

The medical technology field spans a multi-billion dollar market, and corporate competitiveness has long been viewed as the key to staying ahead. But Joe Kiani, Chairman, and CEO of the medical technology company, Masimo, is bringing fierce competitors together for the sake of patient safety. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221005514/en/ Joe Kiani, Founder and Chairman of the Patient Safety Movement Foundation, discusses the importance of open data and interoperability of medical devices. (Photo: Business Wire) As a strong advocate for patient safety, Kiani founded the Patient Safety Movement Foundation to stem the needless deaths that occur in hospitals every day through preventable medical error. The goal is zero preventable deaths by 2020. One of the ways to reach such an aggressive goal, says Kiani, is a concept called “interoperability” and he wants to use open data to create a “Patient Data Super Highw

Mavenir and ADVA Ensemble Partner to Deliver Enterprise LTE Solutions to Managed Service Providers and Enterprises21.2.2018 12:00Pressemelding

Mavenir, focused on transforming mobile network economics for Communications Service Providers, and Ensemble, a Division of ADVA Optical Networking, the leader in Edge NFV solutions, have partnered to provide a complete end-to-end solution for Enterprise LTE. The Enterprise LTE Solution empowers mobile network operators with a revenue-generating solution offering for businesses looking to replace outdated and expensive hardware-based wireless networks. Enterprise solutions require low cost white box architectures that are zero touch from an install perspective. To add complete LTE wireless connectivity to that solution allows the enterprise to install their own partial or complete LTE enterprise wireless that is capable of supporting CBRS and multicarrier solutions. The total global revenue for the private LTE addressable market in industrial and commercial IoT will reach $118.5 billion in 20231. Leveraging NFV as a platform for new and innovative applications, Ensemble and Mavenir hav

The Russian Export Center Will Be Presenting Innovative Russian Solutions at the Mobile World Congress in Barcelona for the First Time21.2.2018 11:21Pressemelding

The Russian Export Center will be introducing home-grown, Russian technology at the 2018 Mobile World Congress (MWC) in Barcelona for the first time. Seventeen Russian companies will showcase their unique, powerful and competitive solutions to a world audience from February 26th to March 1st, from the Russian Booth (Pavilion No. 6, booth 6H20 and 6I11). Information about Russian companies attending is available via the link below: https://drive.google.com/file/d/1pNZ5d8ZOSrC5Ltf_ro_oQVZoo2ylnWqY/view A special business program is organized for the Russian booth, to create opportunities for Russian companies to enter the international market and non-Russian companies to promote their business in Russia. We would like to welcome media and attendees to special events at the Russian Export Center exposition including: - A special session with the leading Russian newspaper "Kommersant", titled "New business opportunities in the digital age" involving Russian and foreign experts (February 26

HSL to Launch a MaaS Interface Open to Everyone on 2 April21.2.2018 11:18Pressemelding

HSL is currently building the world’s first completely open public transport ticketing interface. The interface will allow operators in Finland and abroad to incorporate HSL’s tickets into their array of services. The interface will open for commercial purposes at https://sales-api.hsl.fi on 2 April. HSL is also inviting operators outside the transport sector to develop innovative, new mobility services using the interface. Technical development of the interface will continue and in the future, other tickets may be made available via the interface, in addition to single tickets. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221005630/en/ On 19 February, a so called sandbox environment was opened whereby developers can acquaint themselves with the characteristics of the interface’s production environment, and test the compatibility of their own interfaces with the HSL OpenMaas interface. Schedule for HSL’s OpenMaas service